Skip to main content
Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.925
-0.085 (-8.42%)
May 3, 2024, 3:58 PM EDT - Market closed

Arch Therapeutics Market Cap

Arch Therapeutics has a market cap or net worth of $4.39 million as of May 3, 2024. Its market cap has decreased by -2.08% in one year.

Market Cap
4.39M
Enterprise Value
11.46M
1-Year Change
-2.08%
Ranking
n/a
Category
Nano-Cap
Stock Price
$0.93

Market Cap Chart

Since May 6, 2019, Arch Therapeutics's market cap has decreased from $58.94M to $4.39M, a decrease of -92.56%. That is a compound annual growth rate of -40.54%.

History

DateMarket Cap% Change
May 3, 20244.35M-8.42%
May 2, 20244.75M-14.41%
May 1, 20245.55M-
Apr 24, 20245.55M3.51%
Apr 23, 20245.37M-3.39%
Apr 22, 20245.55M12.38%
Apr 19, 20244.94M-11.02%
Apr 18, 20245.55M1.72%
Apr 17, 20245.46M3.57%
Apr 16, 20245.27M-0.88%
Apr 15, 20245.32M-25.17%
Apr 12, 20247.11M2.03%
Apr 11, 20246.97M-6.92%
Apr 10, 20247.48M-4.22%
Apr 8, 20247.81M-2.35%
Apr 5, 20248.00M-
Apr 4, 20248.00M-
Apr 3, 20248.00M-8.11%
Apr 2, 20248.71M2.78%
Apr 1, 20248.47M-8.16%
Mar 28, 20249.23M7.69%
Mar 27, 20248.57M-6.19%
Mar 26, 20249.13M-9.35%
Mar 25, 202410.07M-
Mar 22, 202410.07M11.46%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 698.52B
Novo Nordisk 566.57B
UnitedHealth Group 453.09B
Johnson & Johnson 359.71B
Merck & Co. 322.94B
AbbVie 290.01B
AstraZeneca 236.67B
Thermo Fisher 218.49B
Market Cap Rankings